These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16143515)

  • 41. The time is ripe.
    Mortimer M
    Nature; 2007 Jun; 447(7146):884. PubMed ID: 17593575
    [No Abstract]   [Full Text] [Related]  

  • 42. Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.
    Bromley CM; Close S; Cohen N; Favis R; Fijal B; Gheyas F; Liu W; Lopez-Correa C; Prokop A; Singer JB; Snapir A; Tchelet A; Wang D; Goldstaub D;
    Pharmacogenomics J; 2009 Feb; 9(1):14-22. PubMed ID: 18794908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Negotiating clinical trial agreements: bridging the gap between research institutions and companies.
    Porter PD; Longmire B; Abrol A
    J Health Life Sci Law; 2009 Apr; 2(3):121-42. PubMed ID: 19485028
    [No Abstract]   [Full Text] [Related]  

  • 44. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of the human genome on the discovery of immune-modulatory therapeutics.
    Manning AM
    Curr Opin Investig Drugs; 2006 May; 7(5):406-11. PubMed ID: 16729715
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical trials: Philadelphia hospitals combine to form "supersite" and reduce delays.
    AIDS Treat News; 2004 Aug; (404):7. PubMed ID: 15484368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Found in translation.
    Shaywitz D; Dansky H
    Nature; 2007 Apr; 446(7136):700. PubMed ID: 17421074
    [No Abstract]   [Full Text] [Related]  

  • 48. Why do we need noncommercial, investigator-initiated clinical trials?
    Tyndall A
    Nat Clin Pract Rheumatol; 2008 Jul; 4(7):354-5. PubMed ID: 18477999
    [No Abstract]   [Full Text] [Related]  

  • 49. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 50. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?
    Elliott C
    New Yorker; 2008 Jan; ():36-41. PubMed ID: 18265451
    [No Abstract]   [Full Text] [Related]  

  • 51. Project selection in the pharmaceutical industry.
    Main P
    Proc R Soc Med; 1976 Dec; 69(12):885-7. PubMed ID: 1013126
    [No Abstract]   [Full Text] [Related]  

  • 52. Silent running: the race to the clinic.
    Nature; 2006 Aug; 442(7103):614-5. PubMed ID: 16900171
    [No Abstract]   [Full Text] [Related]  

  • 53. Biotechs go generic: the same but different.
    Ledford H
    Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194
    [No Abstract]   [Full Text] [Related]  

  • 54. Teaching and research hospitals. CJH clinical research program acts as broker for product trials.
    Siegner CA
    Mod Healthc; 1985 Oct; 15(22):114, 116. PubMed ID: 10273918
    [No Abstract]   [Full Text] [Related]  

  • 55. [Participation in the international multi-countries study-operational issues from company view point].
    Hada S
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):324-7. PubMed ID: 17301555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural products to drugs: natural product-derived compounds in clinical trials.
    Butler MS
    Nat Prod Rep; 2008 Jun; 25(3):475-516. PubMed ID: 18497896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Is the pharmaceutical industry really as bad as its reputation?].
    Prat EH
    Wien Med Wochenschr; 2005 Nov; 155(21-22):502-12. PubMed ID: 16425111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reengineering the pharmaceutical industry by crash-testing molecules.
    Swaan PW; Ekins S
    Drug Discov Today; 2005 Sep; 10(17):1191-200. PubMed ID: 16182212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The profile of the one-time 1572 investigator.
    Glass HE
    Contemp Clin Trials; 2009 Jan; 30(1):34-9. PubMed ID: 18835461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Researchers facing increasing costs for clinical research, with few solutions.
    Erdmann J
    J Natl Cancer Inst; 2005 Oct; 97(20):1492-4. PubMed ID: 16234558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.